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The authors describe the pathophysiological mechanisms leading to development of acidosis in patients with chronic obstructive
pulmonary disease and its deleterious eﬀects on outcome and mortality rate. Renal compensatory adjustments consequent to
acidosis are also described in detail with emphasis on diﬀerences between acute and chronic respiratory acidosis. Mixed acid-base
disturbances due to comorbidity and side eﬀects of some drugs in these patients are also examined, and practical considerations
for a correct diagnosis are provided.
1.Introduction
Chronic obstructive pulmonary disease (COPD) is a major
public health problem. Its prevalence varies according to
country, age, and sex. On the basis of epidemiologic data,
the projection for 2020 indicates that COPD will be the
third leading cause of death worldwide and the ﬁfth leading
cause of disability [1]. About 15% of COPD patients need
admission to general hospital or intensive respiratory care
unit for acute exacerbation, leading to greater use of medical
resources and increased costs [2–5]. Even though the overall
prognosis of COPD patients is lately improved, the mortality
rate remains high, and, among others, acid-base disorders
occurring in these subjects can aﬀect the outcome.
The aim of this paper is to focus on the main pathogenic
mechanisms leading to acid-base disorders and their clinical
consequences in COPD patients.
2. HypercapniaandRespiratory Acidosis
A major complicance in COPD patients is the development
of stable hypercapnia [6, 7].
In the healthy subject, about 16,000–20,000mmol/day of
carbon dioxide (CO2), derived from oxidation of nutrients
containing carbon, are produced. Under normal conditions,
the production of CO2 is removed by pulmonary ventilation.
However, an alteration in respiratory exchanges, as occurs
in advanced phase of COPD, results in retention of CO2.
Carbon dioxide is then hydrated with the formation of
carbonic acid that subsequently dissociates with release of
hydrogen ions (H+) in the body ﬂuids according to the fol-
lowing equation:
CO2 +H 2O =⇒ H2CO3 =⇒
−HCO3 +H +. (1)
Thus, the consequence of hypercapnia due to alteration
of gas exchange in COPD patients mainly consists in increase
of H+ concentration and development of respiratory acido-
sis, also called hypercapnic acidosis [8]. According to the
traditionalmethodtoassessacid-basestatus,theHenderson-
Hasselbach equation expresses the relationship between pH
(logarithm of inverse concentration of H+), bicarbonate
ion concentration (−HCO3), and partial pressure of CO2
(pCO2):
pH = 6.1+log
−HCO3/0.03pCO2. (2)
It is evident that the pH and the concentration of hydro-
gen ions are strictly determined by the bicarbonate/pCO2
ratio, rather than their individual values. A change in pH can
thus be determined by a primitive alteration of numerator of
this equation, that is, bicarbonate (metabolic disorders) orof2 Journal of Biomedicine and Biotechnology
denominator, that is, pCO2 (respiratory disorders). In either
case, compensatory mechanisms are activated to determine a
consensual variation of the other factor to keep this ratio as
constant as possible and minimize changes in pH. The extent
of these compensatory changes are largely dependent on that
oftheprimaryalterationandcanbetosomeextentpredicted
(expected compensatory response) [9].
Consequently, the compensation to respiratory acidosis
consists in a secondary increase in bicarbonate concentra-
tion, and the arterial blood gas analysis is characterized by
a reduced pH, increased pCO2 (initial variation), and in-
creased bicarbonate levels (compensatory response).
3. Compensatory Mechanisms in Acute and
ChronicRespiratoryAcidosis
The response to respiratory acidosis occurs in a diﬀerent
extent either in acute or chronic phase. When hypercapnia
occurs acutely, the buﬀering of H+ takes place by proteins,
mainly hemoglobin, and other intracellular nonbicarbonate
buﬀers as follows:
H2CO3 +
−Hb =⇒ HHb +
−HCO3. (3)
The eﬀectiveness of this mechanism is limited. In such
condition, for every increase of 10mmHg pCO2 we expect
only 1mEq increase in bicarbonate concentration [10].
Subsequently, renal adaptive changes occur mainly in
the proximal tubular cells than in distal tubules leading to
increased bicarbonate reabsorption and increased excretion
of titratable acid and ammonium [11, 12].
H+ excretion across apical membrane occurs by a
Na+/H+ antiporter (NHE3) and to a lesser extent by a proton
pump(Figure 1).ThesecretedH+ intothetubularﬂuidcom-
bines with ﬁltered bicarbonate ions leading to carbonic acid
formation.ThecarbonicanhydraseisthensplitintoCO2 and
H2O. CO2 diﬀuses into the cell where CO2 is rehydrated to
carbonic acid. This gives rise to bicarbonate ion that exits
from the cell through the basolateral membrane into the
interstitium via a 3HCO3/Na (NBCe1) symporter, while H+
is secreted again into the lumen. The basolateral membrane
Na+/K+ ATPase antiporter, maintaining a low intracellular
sodium concentration, further enhances the NHE3 activity.
In summary, reabsorption of bicarbonate requires car-
bonic anhydrase and is strictly associated to natrium reab-
sorption.
Experimental studies show that total NHE3 and NBCe1
protein abundance are upregulated by chronic respiratory
acidosis [13]. However, the main mechanism responsible for
the elevation in serum bicarbonate is the increased excretion
of titratable acid and ammonium [12], which are stimulated
by persistently elevated pCO2.
Ammonia (NH3), in the proximal cell, is formed by
deamination of glutamine to glutamic acid and then to
alpha-ketoglutarate. Therefore, for each molecule of glu-
tamine, two molecules of ammonia are formed (Figure 2).
Ammonia binds H+ resulting in ammonium ion (NH4
+)
which is subsequently secreted into the renal tubular lumen
by NHE3, with NH4
+ substituting for H+ on the transporter,
and excreted into the urine as ammonium chloride (NH4Cl).
For alternative, some NH4
+ can be secreted into the tubular
ﬂuid as NH3, where it is then protonated. Thus, ammonia
replaces bicarbonate ion acting as urinary buﬀer and bind-
ing hydrogen ion. Consequently, for each H+ excreted as
ammonium ion, a “new −HCO3” is returned to the blood.
Nevertheless, a signiﬁcant reabsorption of NH4
+ occurs in
the ascending limb of the loop of Henle. In the distal tubule,
NH4
+ reabsorbed is subsequently excreted by a NH4
+-trans-
porter belonging to Rh glycoproteins family, localized on
both apical and basolateral membranes of collecting duct
cells [14].
Thus, collecting duct cells plays a pivotal role in main-
taining acid-base balance and net acid excretion. If ammo-
nium reabsorbed was not excreted in the urine, it would be
metabolized by the liver generating H+, and a “new −HCO3”
production would be negated.
Inorganic phosphates, particularly in the distal nephron,
also play a role.
H+ derived from the breakdown of carbonic acid are ex-
creted into the tubular lumen where they are buﬀered by
phosphates(2−HPO4 +H + ⇒ −H2PO4),while −HCO3 cross-
es the basolateral membrane via an anion exchange (AE)
Cl−/−HCO3 antiporter (Figure 3).
Phosphates then bind hydrogen ions replacing “regen-
erated” bicarbonate ions. Interestingly, acidemia and hyper-
capnia reduce the threshold for reabsorption of phosphate,
thus making available a larger amount of urinary buﬀer in
the distal tubule [15, 16].
Pendrin is a bicarbonate/chloride exchanger located in
the apical domain of the type B and non-A, non-B inter-
calated cell of collecting ducts (Figure 4). Hypercapnia deter-
mines a reduction of pendrin expression by up to 50%, con-
tributing to the increased plasma bicarbonate and decreased
plasma chloride observed in chronic respiratory acidosis
[11, 17].
The renal response is completed in its full extent after 3–
5 days, resulting in a new steady state in which increase of
3.5mEq in bicarbonate concentration is expected for every
increase of 10mmHg pCO2 [18, 19]. Then, in the setting of
chronic respiratory acidosis, renal compensation oﬀers more
signiﬁcant pH protection in contrast to intracellular buﬀer-
ing in the acute situation.
For example, if we consider an acute pCO2 increase
to 80mmHg, bicarbonate concentration compensatory in-
creases by 4mEq.
In agreement to Henderson-Hasselbach equation,
pH = 6.1 +log(28/0.03 ×80) = 7.17. (4)
Conversely, if we consider a chronic increase of pCO2
to 80mmHg, we could observe a compensatory increase of
about 14mEq in bicarbonate concentration. Thus,
pH = 6.1 +log(38/0.03 ×80) = 7.29. (5)
In the last example, the variation in pH value is signif-
icantly smaller than in the previous one (0.11 versus 0.23
units). This explains why chronic respiratory acidosis is gen-
erally less severe and better tolerated than acute with similarJournal of Biomedicine and Biotechnology 3
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Cl−/−HCO3 exchanger regulating the acid-base status and chloride
homeostasis.
hypercapnia. Figure 5 shows the diﬀerent slope of the rela-
tionshipbetweenpCO2 andbicarbonateinacuteandchronic
respiratory acidosis.
4. ClinicalConsequences of Acidosis
Acidosis is an adverse prognostic indicator and is respon-
sible for several deleterious eﬀects on hemodynamics and
metabolism [20–22]. Acidosis causes myocardial depression,
arrhythmias, decrease of peripheral vascular resistances, and
hypotension. In addition, hypercapnic acidosis is responsible
for weakness of respiratory muscles, increase of proinﬂam-
matory cytokines and apoptosis, and cachexia. Moreover, in
hypercapnic COPD patients a decrease of renal blood ﬂow,
anactivationoftherenin-angiotensinsystem,andincreaseof
circulating values of antidiuretic hormone, atrial natriuretic
peptide, and endothelin-1 have been reported [23]. It has
been supposed that these hormonal abnormalities can play
a role in retention of salt and water and development of
pulmonary hypertension, independently from the presence
of myocardial dysfunction.
Clinical and epidemiological data clearly demonstrate
that severity of acidosis is associate with poor prognosis.
In the study of 139 patients with COPD and respiratory
failure, Jeﬀrey et al. [24] concluded that arterial H+ concen-
tration is an important prognostic factor for survival.
In a retrospective study on 295 episodes of COPD
exacerbation, Guy et al. [25] reported that intubation and
mortality rate was highest at the lowest pH group. Similarly,
Kettel et al. [26]a n dW a r r e ne ta l .[ 27] reported an higher
mortality rate in patients witha pH value at admission below
7.23 and 7.26, respectively. Plant et al. [28] reported that the
more acidemic patients had an higher mortality rate both in
group with conventional therapy and in group undergone
to noninvasive ventilation. Similar ﬁndings were reported by
more recent papers [29–31] conﬁrming that a more severe
acidosis worsens the outcome of COPD patients.
Prognosis of COPD patients is also adversely aﬀected by
comorbidity.Chronicrenalfailurewasfoundassociatedwith
COPD in 22–44% of cases, depending on the study series
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Figure 5: Relationship between pCO2 and bicarbonate in acute and
chronic respiratory acidosis.
and diagnostic criteria [32–34]. Renal failure can contribute
to development of hypertension, peripheral arterial vascular
disease, and onset of ischemic heart disease.
In addition, when renal failure occurs in COPD patients,
the compensatory role of kidney in respiratory acidosis may
be less eﬀective, resulting in a reduced ammoniagenesis
and titratable acidity production with consequent smaller
increase of serum bicarbonate and more severe acidosis.
Clinicalreportsdemonstratedthatbicarbonatelevelsinthese
patients are inversely related to survival and that concomi-
tant renal failure is predictive of death and risk of exacerba-
tion [31, 35, 36].
Thesepreviousclinicalstudiesindirectlyconﬁrmtherole
and the importance of kidney function as compensatory
organ in acid-base disorders.
5.MixedAcid-Base Disorders
Respiratory acidosis is not the only acid-base disturbance
observed in patients with COPD. The presence of comorbid-
ityandsideeﬀectsofsomedrugsusedtotreatCOPDpatients
cause diﬀerent disorders. These conditions are deﬁned as
mixed acid-base disorders.
The main clinical conditions leading to a mixed acid-
base disorder are summarized in Table 1. Heart failure, acute
pulmonary edema, renal failure, and the onset of sepsis or
severe hypoxia are, for example, the most common causes
of metabolic acidosis associated with hypercapnia. An abuse
of diuretics with volume depletion, hypokalaemia, and use
of steroids are the most commonly associated factors with
simultaneous presence of metabolic alkalosis.
Metabolic alkalosis may also be the consequence of a too
rapid removal of CO2 in patients undergoing mechanical
ventilation.Inthesesubjects,thekidneyisnotabletoquickly
remove the bicarbonate excess after the normalization of
CO2 tension, even though some authors hypothesized that
cellular transport processes might have a “memory” of pre-
existing conditions, and increased bicarbonate reabsorption
might persist for some time [13, 37].Journal of Biomedicine and Biotechnology 5
Table 1: Mixed acid-base disturbances in COPD.
Acute on chronic respiratory acidosis Respiratory acidosis and metabolic alkalosis
Reexacerbation of COPD
Volume depletion
Diuretics
Vomiting
Severe hypokalemia
Steroids
Posthypercapnic alkalosis
Respiratory acidosis and metabolic acidosis Resp. acidosis, met. acidosis, and met. alkalosis
Severe hypoxemia
Acute pulmonary edema
Renal failure and vomiting
Severe hypoxemia and volume depletion
Sepsis and hypokalemia
Renal failure
Sepsis
Shock
Diabetes mellitus
Acute alcoholism
Exogenous poisoning
Both metabolic acidosis and metabolic alkalosis can
coexist with respiratory acidosis. This clinical setting may
occur, for example, in patients with COPD who develop
heart failure and are treated with high doses of diuretics or
who have renal failure and vomiting or severe hypoxia and
extracellular volume depletion.
In these cases, even if the ﬁnal shift of the pH depends
on the prevalence of acidogenic or alkalogenic factors, the
production and/or removal of both metabolic bases and in-
organic acids are altered.
Systematically investigated studies on acid-base disorders
in patients with COPD are few, but there are evidences that
about one-third of these patients have multiple disorders in
which the associated respiratory acidosis-metabolic alkalosis
is the most frequently found disorder [38, 39].
The presence of a mixed acid-base disturbance compli-
cates the clinical pathophysiology and poses diﬃculties in
diagnosis and treatment.
AlimitationoftheHenderson-Hasselbachmethodinthis
clinical setting is the dependence of serum bicarbonate on
pCO2. A variation in the bicarbonate level can be due to a
metabolic disorder or can be the consequence of an initial
variation in pCO2. In the mixed disorders, the bicarbonate
level can result in a confounding factor because the altered
bicarbonate value, alone, suggests an acid-base imbalance,
but it does not distinguish the metabolic component from
respiratory component.
Therefore, alternative methods have been proposed to
betterquantifythemetaboliccomponentinmixeddisorders.
Among these, standard base excess (SBE), corrected
anion gap (cAG), and the Stewart approach are the most fre-
quently utilized [40–43].
SBEcanbedeﬁnedastheamountofstrongacidorstrong
base that must be added to each liter of fully oxygenated
blood to restore the pH to 7.40 at a temperature of 37◦C
and pCO2 kept at 40mmHg and hemoglobin concentration
standardized to5g/dL.ThecAGisthediﬀerencebetweenthe
sum of the main cations and the main anions, corrected for
albumin concentration and serum phosphate. Nevertheless,
SBE and cAG do not entirely solve the problem and are been
criticized.
SBE is an approach that extrapolates results “in vitro”
to the more complex multicompartimental real-life situation
of body ﬂuids because, in vivo, acid or base loads are not
only titrated in the blood compartment, and total buﬀering
capacity can be diﬀerent from in vitro.
Furthermore, SBE does not resolve the interdependence
of pCO2 and bicarbonate because, in respiratory disorders,
therenalcompensatoryadjustmentsresultinchangesinSBE.
The cAG should reveal the presence of unmeasured
anions in the blood, and it is useful to determine the cause
of metabolic acidosis (hyperchloremic rather than normo-
chloremic) once it has been diagnosed.
The Stewart approach [43] is based on the principals of
conservation of mass, electrical neutrality, and dissociation
constant of electrolytes and identiﬁed three independent
variables determining hydrogen ion concentration in solu-
tion: strong ion diﬀerence (SID), pCO2, and total weak acid
(Atot). Although Stewart method proposes a diﬀerent ap-
proach, its reliability compared to the traditional method
is still a debated question. Some authors [39, 44, 45]c o n -
sider the diagnostic performance of the Stewart method bet-
ter than the conventional approach to assess acid-base status,
especially to quantify the metabolic component, but others
[46–49] concluded that it does not improve the diagnos-
tic accuracy and does not provide any tool to better man-
age these disorders because the traditional approach, with
only minor adjustments, can provide the same practical in-
formation.
So when and how to suspect a mixed disorder according
to the traditional method?
For this purpose, a stepwise approach has been proposed
by several authors [50–53], and some simple concepts could
help in supposing the presence of a mixed disorder.
(1) Discordant Variation of Bicarbonates and pCO2.
Compensatory mechanisms are aimed to keep constant6 Journal of Biomedicine and Biotechnology
bicarbonate/pCO2 ratio, and a primitive variation of one of
the terms is followed by a consensual variation of the other.
Therefore, increase of bicarbonates and decrease of pCO2
or decrease of bicarbonates and increase of pCO2 suggest a
mixed disorder.
(2) The Presence of Normal pH Value and Signiﬁcant
Alteration in Bicarbonates and pCO2 Levels Also Suggest a
Mixed Disorder. The adaptive mechanisms do not restore the
pH to a normal value. Normal pH, in this case, argues for the
coexistence of two opposing problems rather than a perfectly
compensated simple disorder.
(3) Compensatory Response Is Signiﬁcantly Diﬀerent than
Expected Response. Observed bicarbonate levels or pCO2
signiﬁcantly diﬀerent than “expected” proves the existence
of a mixed disorder. In fact, the amount of compensatory
variation depends on the extension of primitive change,
and it can be reasonably provided. When expected response
does not occur, there is an additive disorder responsible for
variation of bicarbonate or pCO2.
(4) Delta Ratio, That Is, Δanion gap/ΔHCO3 > 2. When
a metabolic acid (HA) is added to extracellular ﬂuid, it
dissociates in H+ and organic anion (−A). H+ react with a
molecule of bicarbonate while unmeasured organic anion
(−A) will increase anion gap (positive less negative charges).
Theoretically, the variation in the anion gap should be equal
to the decrease in bicarbonate so that the ratio between
these two changes should be equal to one. Nevertheless, a
signiﬁcantamountoforganicacidisbuﬀeredbyintracellular
proteins, not by −HCO3, while most of excess anions remain
in the extracellular ﬂuids because they do not freely cross
the cellular membrane. Consequently, in a pure metabolic
acidosis, the change in bicarbonate concentration is lesser
than anion gap, and delta ratio is between 1 and 2. A delta
ratio value above 2 indicates a lesser fall in bicarbonate than
expected on basis of the change in anion gap. This ﬁnding
suggests a concurrent metabolic alkalosis or preexisting high
HCO3 levels due to chronic respiratory acidosis.
In any case, the interpretation of arterial blood gas anal-
ysiscannotignoretheﬁndingsofclinicalhistoryandphysical
examination that can support a correct diagnosis.
Clinicians should also consider the preexisting condi-
tions, drugs usually taken, symptoms presented in the last
days and hours as well as hydration status of patients, the
presence of heart and renal failure, diabetes, hypokalemia, or
signs of sepsis.
Therapyofmixeddisordersisoftendiﬃcult.Theattempt
to correct the pH at all costs with the use of alkaline or
acidifying drugs could be harmful, and the clinician’s atten-
tionshouldbepaidtoidentifyunderlyingpathophysiological
changes.
6. Conclusions
Respiratory acidosis due to hypercapnia is a common and
severe complication observed in patients with chronic ob-
structive pulmonary disease in advanced phase. Develop-
mentofacidosisworsenstheprognosisandisassociatedwith
higher mortality rate. Mechanisms of compensation con-
sist of an increased renal reabsorption of bicarbonate and
increased excretion of H+. These adjustments of renal func-
tion are more eﬀective in chronic form and explain why the
latter is less severe and better tolerated than acute. Mixed
acid-base disorders are also frequently observed in COPD
patients. Clinical history, physical examination, and a careful
evaluation of arterial blood gas analysis may help in proper
diagnosis and targeted therapy.
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